Professor David Price
Chair of Primary Care Respiratory Med
- About
-
- Email Address
- d.price@abdn.ac.uk
- Telephone Number
- +44 (0)1224 437237
- School/Department
- School of Medicine, Medical Sciences and Nutrition
- Publications
-
Page 12 of 18 Results 551 to 600 of 857
Identifying novel factors beyond prior hospitalisations, including biomarkers, associated with future asthma hospitalisation risk from routine UK primary care clinical records
Allergy, vol. 69, pp. 61Contributions to Journals: ArticlesManagement of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns
International journal of chronic obstructive pulmonary disease , vol. 9, pp. 889-905Contributions to Journals: ArticlesIntegrated care pathways for airway diseases (AIRWAYS-ICPs)
European Respiratory Journal, vol. 44, no. 2, pp. 304-323Contributions to Journals: ArticlesDetection of airflow limitation using a handheld spirometer in a primary care setting
Respirology, vol. 19, no. 5, pp. 689-693Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1111/resp.12291
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/4077/1/resp12291.pdf
Current evidence and future research needs for FeNO measurement in respiratory diseases
Respiratory Medicine, vol. 108, no. 6, pp. 830-841Contributions to Journals: ArticlesFluticasone propionate/formoterol fumarate in fixed-dose combination for the treatment of asthma
Expert Review of Respiratory Medicine, vol. 8, no. 3, pp. 275-291Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1586/17476348.2014.905914
Switching patients from other inhaled corticosteroid devices to the Easyhaler(®): historical, matched-cohort study of real-life asthma patients
Journal of Asthma and Allergy, vol. 7, pp. 31-51Contributions to Journals: ArticlesOpportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort
The Lancet. Respiratory medicine, vol. 2, no. 4, pp. 267-276Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/S2213-2600(14)70008-6
Integrating evidence for managing asthma in patients who smoke
Allergy, Asthma & Immunology Research, vol. 6, no. 2, pp. 114-120Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.4168/aair.2014.6.2.114
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/3924/1/aair_6_114.pdf
Long-term, randomized safety study of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) in subjects with chronic rhinitis
The Journal of Allergy and Clinical Immunology: In Practice, vol. 2, no. 2, pp. 179-185Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.jaip.2013.09.019
Types, frequency and impact of asthma triggers on patients' lives: a quantitative study in five European countries
Journal of Asthma, vol. 51, no. 2, pp. 127-135Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.3109/02770903.2013.846369
Complementing the randomized controlled trial evidence base. Evolution not revolution
Annals of the American Thoracic Society, vol. 11 , no. Suppl 2, pp. S92-98Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1513/AnnalsATS.201308-276RM
Quality standards for real-world research. Focus on observational database studies of comparative effectiveness
Annals of the American Thoracic Society, vol. 11 , no. Suppl 2, pp. S99-104Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1513/AnnalsATS.201309-300RM
The arch conference declaration. Helping to further the science of pragmatic research
Annals of the American Thoracic Society, vol. 11 , no. Suppl 2, pp. S83-84Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1513/AnnalsATS.201308-256RM
Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey
npj Primary Care Respiratory Medicine, vol. 24, 14009Contributions to Journals: ArticlesCost-effectiveness of initiating extrafine- or standard size-particle inhaled corticosteroid for asthma in two health-care systems: a retrospective matched cohort study
npj Primary Care Respiratory Medicine, vol. 24, 14081Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1038/npjpcrm.2014.81
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/3807/1/npjpcrm201481.pdf
Interstitial lung disease: raising the index of suspicion in primary care
npj Primary Care Respiratory Medicine, vol. 24, 14054Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1038/npjpcrm.2014.54
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/3750/1/npjpcrm201454.pdf
Is there a rationale and role for long-acting anticholinergic bronchodilators in asthma?
npj Primary Care Respiratory Medicine, vol. 24, 14023Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1038/npjpcrm.2014.23
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/3805/1/npjpcrm201423.pdf
Systems Medicine Approaches for the Definition of Complex Phenotypes in Chronic Diseases and Ageing: From Concept to Implementation and Policies
Current Pharmaceutical Design, vol. 20, no. 38, pp. 5928-5944Contributions to Journals: ArticlesFeasibility and ethics
American Journal of Respiratory and Critical Care Medicine, vol. 188, no. 11, pp. 1368-1369Contributions to Journals: Letters- [ONLINE] DOI: https://doi.org/10.1164/rccm.201307-1250LE
Prescription of inhalers in asthma and COPD: Towards a rational, rapid and effective approach
Respiratory Medicine, vol. 107, no. 12, pp. 1817-1821Contributions to Journals: Review articles- [ONLINE] DOI: https://doi.org/10.1016/j.rmed.2013.09.013
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/11264/1/1_s2.0_S0954611113003788_main.pdf
- [ONLINE] View publication in Scopus
Clinical and cost effectiveness of switching asthma patients from fluticasone-salmeterol to extra-fine particle beclometasone-formoterol: a retrospective matched observational study of real-world patients
Primary Care Respiratory Journal, vol. 22, no. 4, pp. 439-448Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.4104/pcrj.2013.00088
Integrating real-life studies in the global therapeutic research framework
The Lancet. Respiratory medicine, vol. 1, no. 10, pp. e29-e30Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/S2213-2600(13)70199-1
Impact of night-time symptoms in COPD: a real-world study in five European countries
International journal of chronic obstructive pulmonary disease , vol. 8, pp. 595-603Contributions to Journals: ArticlesUsing fractional exhaled nitric oxide (FeNO) to diagnose steroid-responsive disease and guide asthma management in routine care
Clinical and Translational Allergy, vol. 3, no. 1, pp. 37Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1186/2045-7022-3-37
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/3712/1/2045_7022_3_37.pdf
Challenges of COPD diagnosis
Expert Opinion on Medical Diagnostics, vol. 7, no. 6, pp. 543-556Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1517/17530059.2013.842552
Effectiveness of inhaler devices in adult asthma and COPD
European Medical Journal - Respiratory, vol. 1, pp. 64-71Contributions to Journals: ArticlesA New Therapy (MP29-02) Is Effective for the Long-Term Treatment of Chronic Rhinitis
Journal of Investigational Allergology and Clinical Immunology, vol. 23, no. 7, pp. 495-503Contributions to Journals: ArticlesAsthma outcomes and costs of therapy with extrafine beclomethasone and fluticasone
Journal of Allergy and Clinical Immunology, vol. 132, no. 1, pp. 45-54.e10Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.jaci.2013.02.008
Clinically Relevant Effect of a New Intranasal Therapy (MP29-02) in Allergic Rhinitis Assessed by Responder Analysis
International Archives of Allergy and Immunology, vol. 161, no. 4, pp. 369-377Contributions to Journals: ArticlesReal-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthma
Respiratory Medicine, vol. 107, no. 7, pp. 987-1000Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.rmed.2013.03.009
A UK-based cost-utility analysis of indacaterol, a once-daily maintenance bronchodilator for patients with COPD, using real world evidence on resource use
Applied Health Economics and Health Policy, vol. 11, no. 3, pp. 259-274Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1007/s40258-013-0021-5
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/5735/1/COPD.pdf
InternationaL cross-sectIonAl and longItudinal assessment on aSthma cONtrol in European adult patients: the LIAISON study protocol
BMC Pulmonary Medicine, vol. 13, 18Contributions to Journals: ArticlesCharacteristics of patients preferring once-daily controller therapy for asthma and COPD: A retrospective cohort study
Primary Care Respiratory Journal, vol. 22, no. 2, pp. 161-168Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.4104/pcrj.2013.00017
A BOLD statement on how to case-find moderate/severe COPD
European Respiratory Journal, vol. 41, no. 3, pp. 503-504Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1183/09031936.00153512
Effect of montelukast for treatment of asthma in cigarette smokers
Journal of Allergy and Clinical Immunology, vol. 131, no. 3, pp. 763-771.e6Contributions to Journals: ArticlesGOLD COPD categories are not fit for purpose in primary care
The Lancet. Respiratory medicine, vol. 1, no. 1, pp. e17Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/S2213-2600(13)70015-8
Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD
Primary Care Respiratory Journal, vol. 22, pp. 92-100Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.4104/pcrj.2012.00092
Efficacy versus effectiveness trials: informing guidelines for asthma management
Current Opinion in Allergy and Clinical Immunology, vol. 13, no. 1, pp. 50-57Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1097/ACI.0b013e32835ad059
Improving clinical reality in chronic obstructive pulmonary disease economic modelling: Development and validation of a micro-simulation approach
Pharmacoeconomics, vol. 31, pp. 151-161Contributions to Journals: ArticlesManagement of Asthma in School age Children On Therapy (MASCOT): a randomised, double-blind, placebo-controlled, parallel study of efficacy and safety
Health Technology Assessment, vol. 17, no. 4Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.3310/hta17040
What we should learn from the London Olympics
Current Opinion in Allergy and Clinical Immunology, vol. 13, no. 1, pp. 1-3Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1097/ACI.0b013e32835c1b73
Inhaler competence in asthma: common errors, barriers to use and recommended solutions
Respiratory Medicine, vol. 107, no. 1, pp. 37-46Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.rmed.2012.09.017
Effect of Inhaled Corticosteroid Therapy Step-Down and Dosing Regimen on Measures of Asthma Control
Journal of Allergy & Therapy, vol. 4, no. 1, 126Contributions to Journals: ArticlesThe BREATHE study: Breathing REtraining for Asthma - trial of home exercises. A protocol summary of a randomised controlled trial
Primary Care Respiratory Journal, vol. 22, no. 2, pp. PS1-PS7Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.4104/pcrj.2013.00047
Real-world perceptions of inhaled corticosteroid/long-acting β2-agonist combinations in the treatment of asthma
Respiratory Medicine, vol. 106, no. Suppl 1, pp. S4-S8Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/S0954-6111(12)70004-5
The at-risk registers in severe asthma (ARRISA) study: a cluster-randomised controlled trial examining effectiveness and costs in primary care
Thorax, vol. 67, no. 12, pp. 1052-1060Contributions to Journals: Articles- [ONLINE] http://www.ncbi.nlm.nih.gov/pubmed
- [ONLINE] DOI: https://doi.org/10.1136/thoraxjnl-2012-202093
Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis
Allergy and Asthma Proceedings, vol. 33, no. 6, pp. 450-458Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.2500/aap.2012.33.3626
Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs
Journal of Allergy and Clinical Immunology, vol. 130, no. 5, pp. 1049-1062Contributions to Journals: ArticlesThe challenge of recruiting in primary care for a trial of telemonitoring in asthma: an observational study
Pragmatic and Observational Research, vol. 2012, no. 3, pp. 51-55Contributions to Journals: Articles